<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Aging</journal-id>
<journal-title-group>
<journal-title>Frontiers in Aging</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Aging</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2673-6217</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1776990</article-id>
<article-id pub-id-type="doi">10.3389/fragi.2026.1776990</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Immune senescence: a key driver of aging and age-related disorders</article-title>
<alt-title alt-title-type="left-running-head">Luan et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fragi.2026.1776990">10.3389/fragi.2026.1776990</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Luan</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2581826"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Bryan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/36007"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gao</surname>
<given-names>Xingchun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/439358"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing &#x2013; review and editing</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Clinical Research Center, The 924th Hospital of the Chinese People&#x2019;s Liberation Army Joint Logistic Support Force</institution>, <city>Guilin</city>, <state>Guangxi</state>, <country country="CN">China</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Institute of Basic and Translational Medicine, Xi&#x2019;an Medical University</institution>, <city>Xi&#x2019;an</city>, <state>Shaanxi</state>, <country country="CN">China</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Roche (United States)</institution>, <city>Pleasanton, CA</city>, <country country="US">United States</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>Institute of Basic Medical Sciences, School of Basic Medical Science, Xi&#x2019;an Medical University</institution>, <city>Xi&#x2019;an</city>, <state>Shaanxi</state>, <country country="CN">China</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Xingchun Gao, <email xlink:href="mailto:gxc199281003@163.com">gxc199281003@163.com</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-13">
<day>13</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>7</volume>
<elocation-id>1776990</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Luan, Wu and Gao.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Luan, Wu and Gao</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-13">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>aging</kwd>
<kwd>biomarker</kwd>
<kwd>circadian</kwd>
<kwd>Crohn&#x2019;s disease</kwd>
<kwd>immune cell</kwd>
<kwd>immune senescence</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work is supported by the Scientific Research Program Funded by Education Department of Shaanxi Provincial Government (No.23JS049), Natural Science Basic Research Program of Shaanxi (2020JZ-56), Program for Science and Technology Innovation Team in Xi&#x2019;an Medical University (2021TD05), Shaanxi Youth Talents Project, Social Development Project of Shaanxi Provincial Science and Technology Department (2025SF-YBXM-377).</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="7"/>
<page-count count="2"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Aging and the Immune System</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes notes-type="frontiers-research-topic">
<p>Editorial on the Research Topic <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/63957">Immune senescence: a key driver of aging and age-related disorders</ext-link>
</p>
</notes>
</front>
<body>
<p>Aging is a multifaceted biological process characterized by progressive declines in physiological function, increasing susceptibility to diseases such as cancer, infections, autoimmune disorders, and metabolic syndromes (<xref ref-type="bibr" rid="B1">Ajoolabady et al., 2024</xref>; <xref ref-type="bibr" rid="B4">Guo et al., 2022</xref>). A growing body of evidence underscores the critical role of immunosenescence&#x2014;the age-related functional deterioration of the immune system&#x2014;in mediating these vulnerabilities. Immunosenescence disrupts immune surveillance, diminishes vaccine efficacy, elevates cancer risk, and fosters a state of chronic, low-grade inflammation termed &#x201c;inflammaging&#x201d; (<xref ref-type="bibr" rid="B2">Doherty et al., 2025</xref>; <xref ref-type="bibr" rid="B3">Franck et al., 2025</xref>; <xref ref-type="bibr" rid="B5">Liu et al., 2023</xref>). While traditionally viewed as an inevitable aspect of chronological aging, accumulating data reveal significant interindividual variability in immunosenescence trajectories, shaped by genetic predisposition, lifestyle factors, and environmental exposures (<xref ref-type="bibr" rid="B7">Wang et al., 2022</xref>). This heterogeneity underscores the urgent need to identify reliable biomarkers of immune aging and clarify the mechanisms linking immunosenescence to systemic aging and specific pathologies. Accordingly, these efforts&#x2014;elucidating these mechanisms and tracking the process via biomarkers&#x2014;are pivotal for developing targeted strategies to modulate immune function, ultimately mitigating age-related decline and extending health span (<xref ref-type="bibr" rid="B6">Ross et al., 2024</xref>).</p>
<p>These four articles within this Research Topic collectively enhance our understanding of immunosenescence, emphasizing its extensive impact on health and disease. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1599515/full">Ge et al.</ext-link> reveal significant heterogeneity in lymphocyte subsets between infants and older adults, demonstrating that infants possess higher absolute counts of na&#xef;ve and memory T cells, while older adults exhibit increased levels of NK cells. Furthermore, the age-related polarization of the CD4&#x2b;/CD8&#x2b; ratio emerges as a promising biomarker for immunosenescence, offering critical insights to inform age-specific vaccination strategies and immune risk stratification in elderly populations. This shift not only reflects the progressive decline in naive T-cell reserves but also highlights the accumulation of terminally differentiated lymphocytes, which together underscore the systemic dysregulation characteristic of aging immune systems. Building on this, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1616531/full">Zhang et al.</ext-link> establish a direct connection between cellular senescence and the pathogenesis of Crohn&#x2019;s disease (CD), identifying senescence-related gene signatures and key hub genes such as STAT3, IL6, and IL1A that contribute to immune dysregulation and intestinal pathology. By elucidating senescence-related gene signatures that delineate molecular subtypes and correlate with immune dysregulation, their research effectively bridges fundamental aging biology with complex chronic inflammatory disorders. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1502746/full">Lu et al.</ext-link> demonstrate the clinical utility of a simple systemic immune-inflammation index (SII), derived from routine blood counts, as a robust predictor of all-cause and cancer-specific mortality in older adults (&#x2265;60&#xa0;years). This work underscores the translational potential of simple, inflammation-associated metrics in stratifying mortality risk. Finally, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1716985/full">Trebing et al.</ext-link> address a vital methodological consideration in immune aging research by investigating the stability of a composite immune age metric (IMMAX) across the circadian cycle. Their findings validate IMMAX as a reliable biomarker while highlighting the need for standardized sampling timing in immune aging studies. Together, these studies affirm that immunosenescence is not merely a consequence of aging but an active contributor to its pathology, influencing disease susceptibility, progression, and outcomes across diverse contexts.</p>
<p>In summary, the convergence of evidence from these studies solidifies immunosenescence as a fundamental aspect of aging biology. The dynamic interplay between cellular senescence, inflammatory pathways, and circadian rhythms elucidated here presents novel opportunities for biomarker development and therapeutic targeting. Future research should prioritize longitudinal studies to unravel causal relationships between immune aging and systemic decline while leveraging omics technologies to identify precision interventions. By harnessing insights from immunosenescence, we can aspire not only to extend healthspan but also to redefine aging as a modifiable process&#x2014;ultimately transforming our approach to age-related diseases.</p>
</body>
<back>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>JL: Writing &#x2013; original draft. BW: Writing &#x2013; original draft. XG: Supervision, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>Author BW was employed by Roche (United States).</p>
<p>The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s4">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s5">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/154187/overview">Anshu Agrawal</ext-link>, University of California, Irvine, United States</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ajoolabady</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pratico</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Franceschi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Immunosenescence and inflammaging: mechanisms and role in diseases</article-title>. <source>Ageing Res. Rev.</source> <volume>101</volume>, <fpage>102540</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2024.102540</pub-id>
<pub-id pub-id-type="pmid">39395575</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doherty</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Didierlaurent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Age-related changes in the immune system and challenges for the development of age-specific vaccines</article-title>. <source>Ann. Med.</source> <volume>57</volume>, <fpage>2477300</fpage>. <pub-id pub-id-type="doi">10.1080/07853890.2025.2477300</pub-id>
<pub-id pub-id-type="pmid">40110678</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanner</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Tennyson</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Daunizeau</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ferrucci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bandinelli</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Nonuniversality of inflammaging across human populations</article-title>. <source>Nat. Aging</source> <volume>5</volume>, <fpage>1471</fpage>&#x2013;<lpage>1480</lpage>. <pub-id pub-id-type="doi">10.1038/s43587-025-00888-0</pub-id>
<pub-id pub-id-type="pmid">40588649</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Aging and aging-related diseases: from molecular mechanisms to interventions and treatments</article-title>. <source>Signal Transduct. Target Ther.</source> <volume>7</volume> (<issue>7</issue>), <fpage>391</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-022-01251-0</pub-id>
<pub-id pub-id-type="pmid">36522308</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Immunosenescence: molecular mechanisms and diseases</article-title>. <source>Signal Transduct. Target Ther.</source> <volume>8</volume> (<issue>8</issue>), <fpage>200</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-023-01451-2</pub-id>
<pub-id pub-id-type="pmid">37179335</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Noh</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Carmody</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Messer</surname>
<given-names>R. J.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity</article-title>. <source>Nat. Apr</source> <volume>628</volume>, <fpage>162</fpage>&#x2013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-024-07238-x</pub-id>
<pub-id pub-id-type="pmid">38538791</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Immunosenescence, aging and successful aging</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <fpage>942796</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.942796</pub-id>
<pub-id pub-id-type="pmid">35983061</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>